Product Images Bomyntra
View Photos of Packaging, Labels & Appearance
- Figure - tra1b 0001 01
- Figure A - tra1b 0001 02
- Figure B - tra1b 0001 03
- Figure C - tra1b 0001 04
- Figure D - tra1b 0001 05
- Figure 1 - tra1b 0001 06
- logo - tra1b 0001 07
- Principal Display Panel – 120 mg/1.7 mL PFS Carton Label - tra1b 0001 08
- Principal Display Panel – 120 mg/1.7 mL Syringe Label - tra1b 0001 09
- Principal Display Panel – 120 mg/1.7 mL Carton Label - tra1b 0001 10
- Principal Display Panel – 120 mg/1.7 mL Syringe Label - tra1b 0001 11
Product Label Images
The following 11 images provide visual information about the product associated with Bomyntra NDC 65219-672 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - tra1b 0001 01
This text is not readable.*
Figure A - tra1b 0001 02
Figure B - tra1b 0001 03
Figure C - tra1b 0001 04
Figure D - tra1b 0001 05
Figure 1 - tra1b 0001 06
This data showcases calcium levels in two groups along with the administration of Denosumab 120 mg to 23 individuals. The table includes values over several days, showing a gradual decline, and points to a subsequent increase. The corrected calcium values are presented in mmol/L and mа/dL.*
logo - tra1b 0001 07
Principal Display Panel – 120 mg/1.7 mL PFS Carton Label - tra1b 0001 08
This text appears to be related to the product information for an injection called Bomyntra. It is a sterile solution with no preservative and comes in a single-dose prefilled syringe. The injection contains denosumab-bnht and has a dosage of 120 mg/1.7 mL (70 mg/mL). It is meant for subcutaneous use only and should be administered by a healthcare provider. The carton includes one single-dose prefilled syringe and prescribing information. It is important not to accept the product if the seal is broken or missing.*
Principal Display Panel – 120 mg/1.7 mL Syringe Label - tra1b 0001 09
This is a description for a medication named Bomyntra, specifically denosumab-bnht injection. It contains 120 mg and is for subcutaneous use only. The manufacturer is Fresenius Kabi USA, LLC. The medication is only available with a prescription (Rx only).*
Principal Display Panel – 120 mg/1.7 mL Carton Label - tra1b 0001 10
Principal Display Panel – 120 mg/1.7 mL Syringe Label - tra1b 0001 11
This is a prescription medication by Fresenius Kabi. It is an injection with a concentration of 120 mg/1.7 mL (70 mg/mL) intended for subcutaneous use only. The medication comes in a single-dose vial, and any unused portion should be discarded.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
